Behind the Study: Cdkn1a Transcript and Aging

Aging | July 26, 2021
Dr. Judith Campisi discusses her priority research paper published in 2021 by Aging, entitled, "Cdkn1a transcript variant 2 is a marker of aging and cellular senescence." continue reading »

Trending With Impact: Epigenetic Shifts, Aging, and Disease

Aging | July 22, 2021
Researchers from Harvard University and the Broad Institute wrote a theory article, published by Aging in 2021, and entitled, “Shifting epigenetic contexts influence regulatory variation and disease risk.” continue reading »

Behind the Study: COVID-19 and Chronological Aging

Aging | July 19, 2021
Dr. Michael Lisanti describes his 2020 paper published by Aging, entitled, "COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?" continue reading »

Metal Compounds Induce DNA Instability In Cancer Cells

Oncotarget | July 21, 2021
Researchers assayed the chromosome-disrupting capabilities of six terpyridine platinum compounds in cancer cells. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #15

Oncotarget | July 20, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 15. continue reading »

Trending With Impact: Targeted Treatment for Recurrent Ovarian Cancer

Oncotarget | July 15, 2021
In this 2018 paper, researchers studied a new targeted strategy to treat ovarian cancer. continue reading »

Behind the Study: Cdkn1a Transcript and Aging

Spotlight | July 26, 2021
Dr. Judith Campisi discusses her priority research paper published in 2021 by Aging, entitled, "Cdkn1a transcript variant 2 is a marker of aging and cellular senescence." continue reading »

Behind the Study: COVID-19 and Chronological Aging

Spotlight | July 19, 2021
Dr. Michael Lisanti describes his 2020 paper published by Aging, entitled, "COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?" continue reading »

Behind the Study: ONC201, TRAIL, and Breast Cancer

Spotlight | July 5, 2021
Founding Oncotarget Editorial Board Member, Dr. Wafik S. El-Deiry, and recent MD/PhD graduate of Temple University, Dr. Marie D. Ralff, discuss their 2020 paper: “TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic.” continue reading »

Special Collections by Oncotarget: Skin Cancer & Melanoma

News | May 20, 2021
Oncotarget launched a new Special Collection of scientific publications directly related to skin cancer and melanoma research. continue reading »

Impact Journals to Present on Scientific Integrity at SSP Annual Meeting

News | May 19, 2021
Impact Journals is an exhibitor/sponsor and will be presenting its scientific integrity process at the Society for Scholarly Publishing (SSP) Annual Meeting, occurring virtually from May 24-27, 2021. continue reading »

Aging (By Impact Journals) Participates in Week Two of AACR Annual Meeting

News | May 11, 2021
The second week of the American Association for Cancer Research (AACR) Annual Meeting will continue to be a virtual event. Aging, by Impact Journals, is proud to be a participant in week two of the conference, from May 17-21, 2021. continue reading »